Cleared Traditional

K903729 - GOLD GATORS

K903729 is an FDA 510(k) clearance for GOLD GATORS, manufactured by Lead-Lok, Inc.. The device is a Class 2 Cardiovascular device with product code DRY cleared through the Traditional 510(k) pathway after a 29-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1990
Decision
29d
Days
Class 2
Risk

K903729 is an FDA 510(k) clearance for the GOLD GATORS. Classified as Monitor, Blood-gas, On-line, Cardiopulmonary Bypass (product code DRY), Class II - Special Controls.

Submitted by Lead-Lok, Inc. (Sandpoint, US). The FDA issued a Cleared decision on September 14, 1990 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Lead-Lok, Inc. devices

FDA 510(k) Submission Details - K903729

510(k) Number K903729 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 1990
Decision Date September 14, 1990
Days to Decision 29 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRY Device Classification - Class 2, Special Controls

Product Code DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass

All 29
Devices cleared under the same product code (DRY) and FDA review panel - the closest regulatory comparables to K903729.
CDI(TM) 300, 400 & 100, MODIFICATION
K915255 · 3M Company · Jan 1992
CDI(TM) H/S CUVETTE, MODIFICATION
K915265 · 3M Company · Jan 1992
SATURATION/HEMATOCRIT MONITOR SYSTEM
K910421 · Medtronic Vascular · Oct 1991
APPLICARD (EKG)
K900459 · Medi-Globe Corp. · Jul 1990
STOCKERT-SHILEY BUBBLE MONITOR 23-23-01
K881006 · Shiley, Inc. · May 1988
STAT-SAT
K874839 · Gish Biomedical, Inc. · May 1988